137 related articles for article (PubMed ID: 2991253)
21. Angiotensinogen is related to the antitrypsin-antithrombin-ovalbumin family.
Doolittle RF
Science; 1983 Oct; 222(4622):417-9. PubMed ID: 6604942
[TBL] [Abstract][Full Text] [Related]
22. Structure and expression of the gene coding for the human serpin hLS2.
Ragg H; Preibisch G
J Biol Chem; 1988 Aug; 263(24):12129-34. PubMed ID: 2841345
[TBL] [Abstract][Full Text] [Related]
23. Serine protease inhibitor antithrombin III and its messenger RNA in the pathogenesis of Alzheimer's disease.
Kalaria RN; Golde T; Kroon SN; Perry G
Am J Pathol; 1993 Sep; 143(3):886-93. PubMed ID: 8362984
[TBL] [Abstract][Full Text] [Related]
24. A frameshift mutation leading to type 1 antithrombin deficiency and thrombosis.
Olds RJ; Lane DA; Finazzi G; Barbui T; Thein SL
Blood; 1990 Dec; 76(11):2182-6. PubMed ID: 1979501
[TBL] [Abstract][Full Text] [Related]
25. Three novel missense mutations in the antithrombin III (AT3) gene causing recurrent venous thrombosis.
Millar DS; Wacey AI; Ribando J; Melissari E; Laursen B; Woods P; Kakkar VV; Cooper DN
Hum Genet; 1994 Nov; 94(5):509-12. PubMed ID: 7959685
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a cDNA for human protein C inhibitor. A new member of the plasma serine protease inhibitor superfamily.
Suzuki K; Deyashiki Y; Nishioka J; Kurachi K; Akira M; Yamamoto S; Hashimoto S
J Biol Chem; 1987 Jan; 262(2):611-6. PubMed ID: 3027058
[TBL] [Abstract][Full Text] [Related]
27. DdeI polymorphism in intron 5 of the ATIII gene.
Daly ME; Perry DJ
Nucleic Acids Res; 1990 Sep; 18(18):5583. PubMed ID: 1977130
[No Abstract] [Full Text] [Related]
28. The organization of the human-plasminogen-activator-inhibitor-1 gene. Implications on the evolution of the serine-protease inhibitor family.
Strandberg L; Lawrence D; Ny T
Eur J Biochem; 1988 Oct; 176(3):609-16. PubMed ID: 3262512
[TBL] [Abstract][Full Text] [Related]
29. Cloning of the full-length cDNA of porcine antithrombin III and comparison with its human homolog.
Chen Y; Tan W; Qin S; Zhang J; Bu H; Li Y; Lu Y; Cheng J
Comp Med; 2009 Aug; 59(4):372-7. PubMed ID: 19712578
[TBL] [Abstract][Full Text] [Related]
30. Important role of arginine 129 in heparin-binding site of antithrombin III. Identification of a novel mutation arginine 129 to glutamine.
Gandrille S; Aiach M; Lane DA; Vidaud D; Molho-Sabatier P; Caso R; de Moerloose P; Fiessinger JN; Clauser E
J Biol Chem; 1990 Nov; 265(31):18997-9001. PubMed ID: 2229057
[TBL] [Abstract][Full Text] [Related]
31. Quantitative and qualitative congenital deficiency of antithrombin III: a new molecular variant called ATIII-Barcelona 2.
Fontcuberta J; Grau E; Rubio N; Félez J; Rutllant ML
Thromb Res; 1988 Jul; 51(1):75-81. PubMed ID: 3413737
[TBL] [Abstract][Full Text] [Related]
32. Structure and expression of the human angiotensinogen gene. Identification of a unique and highly active promoter.
Fukamizu A; Takahashi S; Seo MS; Tada M; Tanimoto K; Uehara S; Murakami K
J Biol Chem; 1990 May; 265(13):7576-82. PubMed ID: 1692023
[TBL] [Abstract][Full Text] [Related]
33. Ovoinhibitor introns specify functional domains as in the related and linked ovomucoid gene.
Scott MJ; Huckaby CS; Kato I; Kohr WJ; Laskowski M; Tsai MJ; O'Malley BW
J Biol Chem; 1987 Apr; 262(12):5899-907. PubMed ID: 3571241
[TBL] [Abstract][Full Text] [Related]
34. An overview of the mechanism of action of antithrombin and its inherited deficiency states.
Blajchman MA
Blood Coagul Fibrinolysis; 1994 Jan; 5 Suppl 1():S5-11; discussion S59-64. PubMed ID: 8186357
[TBL] [Abstract][Full Text] [Related]
35. Structure of human angiotensinogen gene.
Gaillard I; Clauser E; Corvol P
DNA; 1989 Mar; 8(2):87-99. PubMed ID: 2924688
[TBL] [Abstract][Full Text] [Related]
36. Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant.
Long GL; Chandra T; Woo SL; Davie EW; Kurachi K
Biochemistry; 1984 Oct; 23(21):4828-37. PubMed ID: 6093867
[TBL] [Abstract][Full Text] [Related]
37. Recurrent deletion in the human antithrombin III gene.
Grundy CB; Thomas F; Millar DS; Krawczak M; Melissari E; Lindo V; Moffat E; Kakkar VV; Cooper DN
Blood; 1991 Aug; 78(4):1027-32. PubMed ID: 1868237
[TBL] [Abstract][Full Text] [Related]
38. Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate.
Büller HR; ten Cate JW
Am J Med; 1989 Sep; 87(3B):44S-48S. PubMed ID: 2679070
[TBL] [Abstract][Full Text] [Related]
39. The macrophage-mediated regulation of hepatocyte synthesis of antithrombin III and alpha 1-proteinase inhibitor.
Hoffman M; Fuchs HE; Pizzo SV
Thromb Res; 1986 Mar; 41(5):707-15. PubMed ID: 3485835
[TBL] [Abstract][Full Text] [Related]
40. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.
Schwartz RS; Bauer KA; Rosenberg RD; Kavanaugh EJ; Davies DC; Bogdanoff DA
Am J Med; 1989 Sep; 87(3B):53S-60S. PubMed ID: 2679072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
